Cite
Identification Of Low Risk Group In Infants With Acute Lymphoblastic Leukemia By Flow Cytometric Minimal Residual Disease Measurement At Day 15 Of Interfant-99 and Interfant-06 Protocols Treatment
MLA
Franco Locatelli, et al. Identification Of Low Risk Group In Infants With Acute Lymphoblastic Leukemia By Flow Cytometric Minimal Residual Disease Measurement At Day 15 Of Interfant-99 and Interfant-06 Protocols Treatment. Jan. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....34ef402e96aa64340621473ef3a481d9&authtype=sso&custid=ns315887.
APA
Franco Locatelli, Annamaria Di Meglio, Grigory Tsaur, Paola De Lorenzo, Maria Grazia Valsecchi, Larisa Fechina, Andrea Biondi, Barbara Buldini, Giuseppe Basso, Alexander Popov, Rosanna Parasole, & Emanuella Giarin. (2013). Identification Of Low Risk Group In Infants With Acute Lymphoblastic Leukemia By Flow Cytometric Minimal Residual Disease Measurement At Day 15 Of Interfant-99 and Interfant-06 Protocols Treatment.
Chicago
Franco Locatelli, Annamaria Di Meglio, Grigory Tsaur, Paola De Lorenzo, Maria Grazia Valsecchi, Larisa Fechina, Andrea Biondi, et al. 2013. “Identification Of Low Risk Group In Infants With Acute Lymphoblastic Leukemia By Flow Cytometric Minimal Residual Disease Measurement At Day 15 Of Interfant-99 and Interfant-06 Protocols Treatment,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....34ef402e96aa64340621473ef3a481d9&authtype=sso&custid=ns315887.